Drugs in developing countries

Developing drugs for developing countries.

Infectious and parasitic diseases create enormous health burdens, but because most of the people suffering from these diseases are poor, little is invested in developing treatments. We propose that developers of treatments for neglected diseases receive a "priority review voucher." The voucher could save an average of one year of U.S. Food and Drug Administration (FDA) review and be sold by the...

Affordable drugs for developing countries.

In November 2002, the Common Market for Eastern and Southern Africa (COMESA), Africa’s major free trade bloc, applied to the World Trade Organization (WTO) for the right to manufacture low-cost drugs to treat AIDS. The Secretary General of the Organization Erastus Mwencha, in announcing this move, said that drugs must be cheaper as the world could not continue to see people dying for the sake o...

Companies reduce prices for HIV drugs in developing countries.

This article reports the decision of pharmaceutical companies to reduce the prices of anti-HIV drugs in developing countries. It is stated that some of the companies have pledged to sell the pharmaceuticals at prices just above the manufacturing costs, at a discount of up to 90%. This strategy is part of an unprecedented effort to combat AIDS in sub-Saharan Africa. Participating companies in...

Pricing and patents of HIV/AIDS drugs in developing countries

Counterfeit drugs and medical devices in developing countries

License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be f...